These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 24815488)
1. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression. Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells. Hooshmand S; Ghaderi A; Yusoff K; Karrupiah T; Rosli R; Mojtahedi Z Cell Adh Migr; 2013; 7(3):297-303. PubMed ID: 23563506 [TBL] [Abstract][Full Text] [Related]
3. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. Jiang Q; Zhang H; Zhang P J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884 [TBL] [Abstract][Full Text] [Related]
4. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells. Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100 [TBL] [Abstract][Full Text] [Related]
5. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro. Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118 [TBL] [Abstract][Full Text] [Related]
6. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor. Bian YL; Qi YX; Yan ZQ; Long DK; Shen BR; Jiang ZL Eur J Cell Biol; 2008 Feb; 87(2):101-10. PubMed ID: 17963997 [TBL] [Abstract][Full Text] [Related]
7. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration. Aka JA; Zerradi M; Houle F; Huot J; Lin SX Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413 [TBL] [Abstract][Full Text] [Related]
8. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression. Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248 [TBL] [Abstract][Full Text] [Related]
9. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line. Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370 [TBL] [Abstract][Full Text] [Related]
10. Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings. Cigna D; D'Anna C; Zizzo C; Francofonte D; Sorrentino I; Colomba P; Albeggiani G; Armini A; Bianchi L; Bini L; Duro G Mol Biosyst; 2013 Jun; 9(6):1162-8. PubMed ID: 23385635 [TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9. Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1. Bhowmik T; Gomes A Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778 [TBL] [Abstract][Full Text] [Related]
13. Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells. Reimer J; Bien S; Sonnemann J; Beck JF; Wieland T; Kroemer HK; Ritter CA Anticancer Drugs; 2007 Mar; 18(3):333-40. PubMed ID: 17264767 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma. Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343 [TBL] [Abstract][Full Text] [Related]
15. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis. Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911 [TBL] [Abstract][Full Text] [Related]
16. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883 [TBL] [Abstract][Full Text] [Related]
17. Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer. Huang D; Lu W; Zou S; Wang H; Jiang Y; Zhang X; Li P; Songyang Z; Wang L; Wang J; Huang J; Fang L Cancer Sci; 2017 Jul; 108(7):1293-1302. PubMed ID: 28417530 [TBL] [Abstract][Full Text] [Related]
18. Propofol and bupivacaine in breast cancer cell function in vitro - role of the NET1 gene. Ecimovic P; Murray D; Doran P; Buggy DJ Anticancer Res; 2014 Mar; 34(3):1321-31. PubMed ID: 24596379 [TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion. Cho HJ; Kim JT; Lee SJ; Hwang YS; Park SY; Kim BY; Yoo J; Hong KS; Min JK; Lee CH; Lim JS; Yoon SR; Choi I; Choe YK; Lee HG Cancer Lett; 2018 Mar; 417():141-151. PubMed ID: 29307615 [TBL] [Abstract][Full Text] [Related]
20. 14-3-3τ promotes breast cancer invasion and metastasis by inhibiting RhoGDIα. Xiao Y; Lin VY; Ke S; Lin GE; Lin FT; Lin WC Mol Cell Biol; 2014 Jul; 34(14):2635-49. PubMed ID: 24820414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]